Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp reports results for the quarter ended in June - Earnings Summary

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 43
cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 44
cents per share.
    * Revenue rose 23.3% to $17.19 million from a year ago;
analysts
expected $15.86 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 43
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulmonx Corp shares had risen by 5.3% this quarter and
gained 63.8% so far this year.
    * The company reported a quarterly loss of $16.2 million.
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 09:45 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.44          -0.43          Beat
 Mar. 31 2023      -0.44          -0.42          Beat
 Dec. 31 2022      -0.42          -0.38          Beat
 Sep. 30 2022      -0.40          -0.38          Beat

Recent news on Pulmonx

See all news